T2DM: Fact versus fallacy in a COVID-19 world

Expert advice for GPs on navigating these unchartered waters
Sponsored
6
14 April 2020
Save
Please login to bookmark Close
A/Prof Sof Andrikopoulos
Associate Professor Sof Andrikopoulos

This content has been produced by ADG, made possible through an independent educational sponsorship from MSD.

In this COVID-19 era, fake news and misinformation appear to be spreading as fast as the virus itself even within the once sacred domain of medicine.

Anecdotal reports around the dangers of ibuprofen for COVID-19 patients are rife while the role of antihypertensives has come under scrutiny after reports that ACE inhibitors and angiotensin receptors blockers (ARBs) may increase the risk of COVID-19 infection and severity of symptoms.

Even a popular class of antidiabetic agent has come under the spotlight causing confusion around the safety of SGLT2-inhibitors for these patients.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .